These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9185588

  • 1. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein.
    Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M, Simizu B.
    Virology; 1997 May 26; 232(1):53-61. PubMed ID: 9185588
    [Abstract] [Full Text] [Related]

  • 2. Position and orientation independent transactivation by c-Myc.
    Packham G, Bello-Fernandez C, Cleveland JL.
    Cell Mol Biol Res; 1994 May 26; 40(7-8):699-706. PubMed ID: 7787888
    [Abstract] [Full Text] [Related]

  • 3. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS.
    Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150
    [Abstract] [Full Text] [Related]

  • 4. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC.
    Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878
    [Abstract] [Full Text] [Related]

  • 5. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6.
    Inoue T, Oka K, Yong-Il H, Vousden KH, Kyo S, Jing P, Hakura A, Yutsudo M.
    Mol Carcinog; 1998 Mar 17; 21(3):215-22. PubMed ID: 9537653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
    Mol PC, Wang RH, Batey DW, Lee LA, Dang CV, Berger SL.
    Mol Cell Biol; 1995 Dec 17; 15(12):6999-7009. PubMed ID: 8524267
    [Abstract] [Full Text] [Related]

  • 8. Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16.
    Shirasawa H, Jin MH, Shimizu K, Akutsu N, Shino Y, Simizu B.
    Virology; 1994 Aug 15; 203(1):36-42. PubMed ID: 8030282
    [Abstract] [Full Text] [Related]

  • 9. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E.
    Gynecol Oncol; 2004 Jul 15; 94(1):40-7. PubMed ID: 15262117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
    Murvai M, Borbély AA, Kónya J, Gergely L, Veress G.
    Arch Virol; 2004 Dec 15; 149(12):2379-92. PubMed ID: 15290353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen IS, Liu X.
    Oncogene; 2005 Jul 28; 24(32):5069-78. PubMed ID: 15856013
    [Abstract] [Full Text] [Related]

  • 17. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
    Giovane C, Trave G, Briones A, Lutz Y, Wasylyk B, Weiss E.
    J Mol Recognit; 1999 Jul 28; 12(2):141-52. PubMed ID: 10398405
    [Abstract] [Full Text] [Related]

  • 18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter.
    Veldman T, Liu X, Yuan H, Schlegel R.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8211-6. PubMed ID: 12821782
    [Abstract] [Full Text] [Related]

  • 20. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ, Hong Y, Androphy EJ.
    Virology; 1997 Sep 15; 236(1):30-6. PubMed ID: 9299614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.